|
|
||||||||
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190
Dendritic cells (DC) can be divided into three subsets, Langerhans cells, myeloid DC (MDC), and lymphoid DC (LDC), based upon phenotypic and functional differences. We hypothesized that different DC subsets are associated with the development of protective vs nonprotective cell-mediated immune (CMI) responses against the fungal pathogen, Cryptococcus neoformans. To test this, mice were immunized with protective and/or nonprotective immunogens, and DC subsets in draining lymph nodes were assessed by flow cytometry. The protective immunogen (cryptococcal culture filtrate Ag-CFA), in contrast to the nonprotective immunogen (heat-killed cryptococci-CFA), the nonprotective immunogen mixed with the protective immunogen (cryptococcal culture filtrate Ag + heat-killed cryptococci-CFA), or controls, stimulated significant increases in total leukocytes, Langerhans cells, MDC, LDC, and activated CD4+ T cells in draining lymph nodes. The protective immune response resulted in significantly increased levels of anticryptococcal delayed-type hypersensitivity reactivity and activated CD4+ T cells at the delayed-type hypersensitivity reaction site. Draining lymph node LDC:MDC ratios induced by the protective immunogen were significantly lower than the ratios induced by either immunization in which the nonprotective immunogen was present. In contrast, mice given the nonprotective immunogen had LDC:MDC ratios similar to those of naive mice. Our data indicate that lymph node Langerhans cells and MDC are APC needed for induction of the protective response. The predominance of LDC in mice undergoing nonprotective responses suggests that lymph node LDC, like splenic LDC, are negative regulators of CMI responses. In addition to showing DC subsets associated with functional differences, our data suggest that the LDC:MDC balance, which can be modulated by the Ag, determines whether protective or nonprotective anticryptococcal CMI responses develop.
This article has been cited by other articles:
![]() |
E. K. Wansley, M. Chakraborty, K. W. Hance, M. B. Bernstein, A. L. Boehm, Z. Guo, D. Quick, A. Franzusoff, J. W. Greiner, J. Schlom, et al. Vaccination with a Recombinant Saccharomyces cerevisiae Expressing a Tumor Antigen Breaks Immune Tolerance and Elicits Therapeutic Antitumor Responses Clin. Cancer Res., July 1, 2008; 14(13): 4316 - 4325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dan, R. M. Kelly, C. K. Lee, and S. M. Levitz Role of the Mannose Receptor in a Murine Model of Cryptococcus neoformans Infection Infect. Immun., June 1, 2008; 76(6): 2362 - 2367. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pericolini, E. Cenci, E. Gabrielli, S. Perito, P. Mosci, F. Bistoni, and A. Vecchiarelli Indinavir influences biological function of dendritic cells and stimulates antifungal immunity J. Leukoc. Biol., May 1, 2008; 83(5): 1286 - 1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Milam, A. C. Herring-Palmer, R. Pandrangi, R. A. McDonald, G. B. Huffnagle, and G. B. Toews Modulation of the Pulmonary Type 2 T-Cell Response to Cryptococcus neoformans by Intratracheal Delivery of a Tumor Necrosis Factor Alpha-Expressing Adenoviral Vector Infect. Immun., October 1, 2007; 75(10): 4951 - 4958. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Wozniak, J. M. Vyas, and S. M. Levitz In Vivo Role of Dendritic Cells in a Murine Model of Pulmonary Cryptococcosis Infect. Immun., July 1, 2006; 74(7): 3817 - 3824. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. LeBlanc, M. M. Barousse, and P. L. Fidel Jr. Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis. Infect. Immun., June 1, 2006; 74(6): 3213 - 3221. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rivera, H. L. Van Epps, T. M. Hohl, G. Rizzuto, and E. G. Pamer Distinct CD4+-T-Cell Responses to Live and Heat-Inactivated Aspergillus fumigatus Conidia Infect. Immun., November 1, 2005; 73(11): 7170 - 7179. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kelly, J. Chen, L. E. Yauch, and S. M. Levitz Opsonic Requirements for Dendritic Cell-Mediated Responses to Cryptococcus neoformans Infect. Immun., January 1, 2005; 73(1): 592 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Del Poeta Role of Phagocytosis in the Virulence of Cryptococcus neoformans Eukaryot. Cell, October 1, 2004; 3(5): 1067 - 1075. [Full Text] [PDF] |
||||
![]() |
A. Vecchiarelli, D. Pietrella, P. Lupo, F. Bistoni, D. C. McFadden, and A. Casadevall The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation J. Leukoc. Biol., September 1, 2003; 74(3): 370 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Bauman, G. B. Huffnagle, and J. W. Murphy Effects of Tumor Necrosis Factor Alpha on Dendritic Cell Accumulation in Lymph Nodes Draining the Immunization Site and the Impact on the Anticryptococcal Cell-Mediated Immune Response Infect. Immun., January 1, 2003; 71(1): 68 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Syme, J. C. L. Spurrell, E. K. Amankwah, F. H. Y. Green, and C. H. Mody Primary Dendritic Cells Phagocytose Cryptococcus neoformans via Mannose Receptors and Fc{gamma} Receptor II for Presentation to T Lymphocytes Infect. Immun., November 1, 2002; 70(11): 5972 - 5981. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Nichols, S. K. Bauman, F. B. Schafer, and J. W. Murphy Differences in Components at Delayed-Type Hypersensitivity Reaction Sites in Mice Immunized with Either a Protective or a Nonprotective Immunogen of Cryptococcus neoformans Infect. Immun., February 1, 2002; 70(2): 591 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Drake III, M. L. Shawver, A. Hadley, E. Butz, C. Maliszewski, and A. E. Lukacher Induction of Polyomavirus-Specific CD8+ T Lymphocytes by Distinct Dendritic Cell Subpopulations J. Virol., January 1, 2001; 75(1): 544 - 547. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |